TY - JOUR
T1 - Safety protocols, precautions, and countermeasures aboard the International Space Station to prevent ocular injury
AU - Suh, Alex
AU - Ditelberg, Sarah
AU - Szeto, Jonathan J.
AU - Kumar, Divy
AU - Ong, Joshua
AU - Robert Gibson, C.
AU - Mader, Thomas H.
AU - Waisberg, Ethan
AU - Lee, Andrew G.
N1 - Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2025/9/1
Y1 - 2025/9/1
N2 - The International Space Station (ISS) is a $100 billion epicenter of human activity in the vacuum of space that displays mankind's collective endeavor to explore the cosmic frontier. Even within the marvels of technological sophistication aboard the ISS, the human eye remains a highly vulnerable structure. In the absence of multiple layers of protection and risk assessments, crewmembers would face a substantial increase in vulnerability to ocular injury. Aside from stringent preflight screening criteria for astronauts, the ISS is equipped with ophthalmic medications, environmental control and life support systems (e.g., humidity regulation, carbon dioxide removal, pressurized device regulators), and radiation protection to reduce ocular injury. Moreover, additional countermeasures are currently being developed to mitigate the effects of spaceflight-associated neuro-ocular syndrome (SANS) and lunar dust toxicity for the Artemis Program missions. The success of future endeavors hinges not only on continued technological innovation, but also respecting the intricate interplay between human physiology and the extraterrestrial environments. Establishing habitations on the Moon and Mars, as well as NASA's Gateway Program (humanity's first space station around the Moon), will introduce a new set of challenges, underscoring the necessity for continuous insights into ocular health in space. We discuss the safety protocols, precautions, and countermeasures implemented on the ISS to prevent ocular injury – an aspect often overshadowed by the grandeur of space exploration.
AB - The International Space Station (ISS) is a $100 billion epicenter of human activity in the vacuum of space that displays mankind's collective endeavor to explore the cosmic frontier. Even within the marvels of technological sophistication aboard the ISS, the human eye remains a highly vulnerable structure. In the absence of multiple layers of protection and risk assessments, crewmembers would face a substantial increase in vulnerability to ocular injury. Aside from stringent preflight screening criteria for astronauts, the ISS is equipped with ophthalmic medications, environmental control and life support systems (e.g., humidity regulation, carbon dioxide removal, pressurized device regulators), and radiation protection to reduce ocular injury. Moreover, additional countermeasures are currently being developed to mitigate the effects of spaceflight-associated neuro-ocular syndrome (SANS) and lunar dust toxicity for the Artemis Program missions. The success of future endeavors hinges not only on continued technological innovation, but also respecting the intricate interplay between human physiology and the extraterrestrial environments. Establishing habitations on the Moon and Mars, as well as NASA's Gateway Program (humanity's first space station around the Moon), will introduce a new set of challenges, underscoring the necessity for continuous insights into ocular health in space. We discuss the safety protocols, precautions, and countermeasures implemented on the ISS to prevent ocular injury – an aspect often overshadowed by the grandeur of space exploration.
KW - International space station
KW - Long-duration spaceflight
KW - Management
KW - Ocular injuries
KW - Space medicine
KW - Humans
KW - Astronauts
KW - Eye Injuries/prevention & control
KW - Space Flight
UR - https://www.scopus.com/pages/publications/85218164365
UR - https://www.scopus.com/inward/citedby.url?scp=85218164365&partnerID=8YFLogxK
U2 - 10.1016/j.survophthal.2024.08.005
DO - 10.1016/j.survophthal.2024.08.005
M3 - Review article
C2 - 39236988
AN - SCOPUS:85218164365
SN - 0039-6257
VL - 70
SP - 1003
EP - 1012
JO - Survey of Ophthalmology
JF - Survey of Ophthalmology
IS - 5
ER -